The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
A novel method for the in vivo isolation of circulating tumor cells from peripheral blood of cancer patients using a functionalized and structured medical wire
Open accessAbstract
The isolation of circulating tumor cells (CTCs) from the blood of patients afflicted with solid malignant tumors becomes increasingly important as it may serve as a 'liquid biopsy' with the potential of monitoring the course of the cancer disease and its response to cancer therapy, with subsequent molecular characterization. For this purpose, we functionalized a structured medical Seldinger guidewire (FSMW), normally used to obtain safe access to blood vessels and other organ cavities, with a chimeric monoclonal antibody directed to the cell surface expressed epithelial cell surface adhesion molecule (EpCAM). This medical device was optimized in vitro and its biocompatibility was tested according to the regulations for medical devices and found to be safe with no noteworthy side effects. Suitability, specificity and sensitivity of the FSMW to catch and enrich CTCs in vivo from circulating peripheral blood were tested in 24 breast cancer or non-small cell lung cancer (NSCLC) patients and in 29 healthy volunteers. For this, the FSMW was inserted through a standard venous cannula into the cubital veins of healthy volunteers or cancer patients for the duration of 30 min. After removal, CTCs were identified by immuno-cytochemical staining of EpCAM and/or cytokeratins and staining of their nuclei and counted. The FSMW successfully enriched EpCAM-positive CTCs from 22 of the 24 patients, with a median of 5.5 (0-50) CTCs in breast cancer (n=12) and 16 (2-515) CTCs in NSCLC (n=12). CTCs could be isolated across all tumor stages, including early stage cancer, in which distant metastases were not yet diagnosed, while no CTCs could be detected in healthy volunteers. In this observatory study, no adverse effects were noted. Evidently, the FSMW has the potential to become an important device to enrich CTCs in vivo for monitoring the course of the cancer disease and the efficacy of anticancer treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer
Cristofanilli, M., Budd, G. T., Ellis, M. J., Stopeck, A., Matera, J., Miller, M. C., Reuben, J. M., Doyle, G. V., Allard, W. J., Terstappen, L. W. M. M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040766 · Cited by 4,593
Isolation of rare circulating tumour cells in cancer patients by microchip technology
Nagrath, S., Sequist, L. V., Maheswaran, S., Bell, D. W., Irimia, D., Ulkus, L., Smith, M. R., Kwak, E. L., Digumarthy, S., Muzikansky, A., et al. (2007) · Nature · doi:10.1038/nature06385 · Cited by 3,559
Allard, W. J., Matera, J., Miller, M. C., Repollet, M., Connelly, M. C., Rao, C., Tibbe, A. G. J., Uhr, J. W., & Terstappen, L. W. M. M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0378 · Cited by 2,542 · cited 4×
“Patients with metastasized cancer diseases exhibit detectable numbers of CTC in their blood (17), however, since all ex vivo detection systems are limited by the blood volume that can be obtained from the patients or handled by the detection system (18), these technologies are of relatively low sensitivity.”
BackgroundInfluentialde Bono, J. S., Scher, H. I., Montgomery, R. B., Parker, C., Miller, M. C., Tissing, H., Doyle, G. V., Terstappen, L. W. W. M., Pienta, K. J., & Raghavan, D. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0872 · Cited by 2,182
Cohen, S. J., Punt, C. J. A., Iannotti, N., Saidman, B. H., Sabbath, K. D., Gabrail, N. Y., Picus, J., Morse, M., Mitchell, E., Miller, M. C., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.8923 · Cited by 1,841
Detection of Mutations in EGFR in Circulating Lung-Cancer Cells
Maheswaran, S., Sequist, L. V., Nagrath, S., Ulkus, L., Brannigan, B., Collura, C. V., Inserra, E., Diederichs, S., Iafrate, A. J., Bell, D. W., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800668 · Cited by 1,617
Riethdorf, S., Fritsche, H., Müller, V., Rau, T., Schindlbeck, C., Rack, B., Janni, W., Coith, C., Beck, K., Jänicke, F., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1695 · Cited by 1,338
Circulating Tumor Cells: A Novel Prognostic Factor for Newly Diagnosed Metastatic Breast Cancer
Cristofanilli, M., Hayes, D. F., Budd, G. T., Ellis, M. J., Stopeck, A., Reuben, J. M., Doyle, G. V., Matera, J., Allard, W. J., Miller, M. C., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.08.140 · Cited by 1,135
Diverse somatic mutation patterns and pathway alterations in human cancers
Kan, Z., Jaiswal, B. S., Stinson, J., Janakiraman, V., Bhatt, D., Stern, H. M., Yue, P., Haverty, P. M., Bourgon, R., Zheng, J., et al. (2010) · Nature · doi:10.1038/nature09208 · Cited by 1,027
Circulating tumor cells (CTC) detection: Clinical impact and future directions
Paterlini-Brechot, P., & Benali, N. L. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.014 · Cited by 947
Prognostic significance of circulating tumor cells in patients with metastatic colorectal cancer
Cohen, S. J., Punt, C. J. A., Iannotti, N., Saidman, B. H., Sabbath, K. D., Gabrail, N. Y., Picus, J., Morse, M. A., Mitchell, E., Miller, M. C., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn786 · Cited by 513
Isolation of rare cells from cell mixtures by dielectrophoresis
Gascoyne, P. R. C., Noshari, J., Anderson, T. J., & Becker, F. F. (2009) · ELECTROPHORESIS · doi:10.1002/elps.200800373 · Cited by 436
Circulating Tumor Cells as a Window on Metastasis Biology in Lung Cancer
Hou, J.-M., Krebs, M., Ward, T., Sloane, R., Priest, L., Hughes, A., Clack, G., Ranson, M., Blackhall, F., & Dive, C. (2011) · The American Journal of Pathology · doi:10.1016/j.ajpath.2010.12.003 · Cited by 426
Farace, F., Massard, C., Vimond, N., Drusch, F., Jacques, N., Billiot, F., Laplanche, A., Chauchereau, A., Lacroix, L., Planchard, D., et al. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.294 · Cited by 407
Lecharpentier, A., Vielh, P., Perez-Moreno, P., Planchard, D., Soria, J. C., & Farace, F. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.405 · Cited by 367
Metastasis: a therapeutic target for cancer
Steeg, P. S., & Theodorescu, D. (2008) · Nature Clinical Practice Oncology · doi:10.1038/ncponc1066 · Cited by 332
Pachmann, K., Camara, O., Kavallaris, A., Krauspe, S., Malarski, N., Gajda, M., Kroll, T., Jörke, C., Hammer, U., Altendorf-Hofmann, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.6523 · Cited by 280
Xenidis, N., Perraki, M., Kafousi, M., Apostolaki, S., Bolonaki, I., Stathopoulou, A., Kalbakis, K., Androulakis, N., Kouroussis, C., Pallis, T., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.5948 · Cited by 263
Circulating tumour cells: their utility in cancer management and predicting outcomes
Krebs, M. G., Hou, J.-M., Ward, T. H., Blackhall, F. H., & Dive, C. (2010) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834010378414 · Cited by 259
Circulating tumour cells in clinical practice: Methods of detection and possible characterization
Alunni-Fabbroni, M., & Sandri, M. T. (2010) · Methods · doi:10.1016/j.ymeth.2010.01.027 · Cited by 250
Single circulating tumor cell detection and overall survival in nonmetastatic breast cancer
Bidard, F.-C., Mathiot, C., Delaloge, S., Brain, E., Giachetti, S., de Cremoux, P., Marty, M., & Pierga, J.-Y. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp391 · Cited by 232
Circulating Tumor Cell Isolation and Diagnostics: Toward Routine Clinical Use
van de Stolpe, A., Pantel, K., Sleijfer, S., Terstappen, L. W., & den Toonder, J. M. J. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1254 · Cited by 218
Statistical considerations for enumeration of circulating tumor cells
Tibbe, A. G. J., Miller, M. C., & Terstappen, L. W. M. M. (2007) · Cytometry Part A · doi:10.1002/cyto.a.20369 · Cited by 215
Coumans, F. A. W., Doggen, C. J. M., Attard, G., de Bono, J. S., & Terstappen, L. W. M. M. (2010) · Annals of Oncology · doi:10.1093/annonc/mdq030 · Cited by 210
Allan, A. L., & Keeney, M. (2010) · Journal of Oncology · doi:10.1155/2010/426218 · Cited by 196
Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance
Sun, Y.-F., Yang, X.-R., Zhou, J., Qiu, S.-J., Fan, J., & Xu, Y. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-0988-y · Cited by 184
Poveda, A., Kaye, S. B., McCormack, R., Wang, S., Parekh, T., Ricci, D., Lebedinsky, C. A., Tercero, J. C., Zintl, P., & Monk, B. J. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.05.028 · Cited by 180
Circulating tumour cells, their role in metastasis and their clinical utility in lung cancer
O’Flaherty, J. D., Gray, S., Richard, D., Fennell, D., O’Leary, J. J., Blackhall, F. H., & O’Byrne, K. J. (2012) · Lung Cancer · doi:10.1016/j.lungcan.2011.10.018 · Cited by 163
Apoptosis of circulating tumor cells in prostate cancer patients
Larson, C. J., Moreno, J. G., Pienta, K. J., Gross, S., Repollet, M., O'Hara, S. M., Russell, T. B., & Terstappen, L. W. M. M. (2004) · Cytometry Part A · doi:10.1002/cyto.a.20073 · Cited by 151
Flores, L. M., Kindelberger, D. W., Ligon, A. H., Capelletti, M., Fiorentino, M., Loda, M. F., Cibas, E. S., Janne, P. A., & Krop, I. E. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605676 · Cited by 137
Detection of Mutations in EGFR in Circulating Lung-Cancer Cells
Tanoue, L. T. (2010) · Yearbook of Pulmonary Disease · doi:10.1016/s8756-3452(09)79360-0 · Cited by 135
Xu, F., Li, Y., Kang, E. T., & Neoh, K. G. (2005) · Biomacromolecules · doi:10.1021/bm050071w · Cited by 134
Hofman, V., Ilié, M., Bonnetaud, C., Selva, É., Long-Mira, É., Molina, T. J., Vignaud, J.-M., Fléjou, J. F., Lantuéjoul, S., Piaton, É., et al. (2010) · American Journal of Clinical Pathology · doi:10.1309/ajcp9x8ozbeiqvvi · Cited by 125
Rolle, A., Günzel, R., Pachmann, U. A., Willen, B., Höffken, K., & Pachmann, K. (2005) · World Journal of Surgical Oncology · doi:10.1186/1477-7819-3-18 · Cited by 118
Detection of circulating tumor cells in advanced head and neck cancer using the cellsearch system
Nichols, A. C., Lowes, L. E., Szeto, C. C. T., Basmaji, J., Dhaliwal, S. S., Chapeskie, C., Todorovic, B., Read, N. E., Venkatesan, V., Hammond, A., et al. (2011) · Head & Neck · doi:10.1002/hed.21941 · Cited by 117
Fehm, T. N., Solomayer, E., Meng, S., Tucker, T. F., Lane, N., Wang, J., & Gebauer, G. (2005) · Cytotherapy · doi:10.1080/14653240510027082 · Cited by 112
Circulating tumour cell detection on its way to routine diagnostic implementation?
Sleijfer, S., Gratama, J.-W. C., Sieuwerts, A. M., Kraan, J., Martens, J. W. M., & Foekens, J. A. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.09.016 · Cited by 105
Circulating tumor cells: finding the needle in the haystack.
Xu, Z., Cher, M. L., & Bonfil, R. D. (2011) · PubMed · Cited by 99
Circulating and Disseminated Tumor Cells in the Management of Breast Cancer
Ross, J. S., & Slodkowska, E. A. (2009) · American Journal of Clinical Pathology · doi:10.1309/ajcpji7deolkcs6f · Cited by 91
Circulating Tumor Cells: Evolving Evidence and Future Challenges
Dotan, E., Cohen, S. J., Alpaugh, K. R., & Meropol, N. J. (2009) · The Oncologist · doi:10.1634/theoncologist.2009-0094 · Cited by 81
Nedosekin, D. A., Sarimollaoglu, M., Ye, J., Galanzha, E. I., & Zharov, V. P. (2011) · Cytometry Part A · doi:10.1002/cyto.a.21102 · Cited by 77
Circulating tumor cells in breast cancer: A tool whose time has come of age
Swaby, R. F., & Cristofanilli, M. (2011) · BMC Medicine · doi:10.1186/1741-7015-9-43 · Cited by 65
Oncologic Phase 0 Trials Incorporating Clinical Pharmacodynamics: from Concept to Patient
Doroshow, J. H., & Parchment, R. E. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4562 · Cited by 62
Mostert, B., Kraan, J., Sieuwerts, A. M., van der Spoel, P., Vries, J. B., der Smissen, W. J. C. P., Smid, M., Timmermans, A. M., Martens, J. W. M., Gratama, J. W., et al. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.12.031 · Cited by 51
Molloy, T. J., Devriese, L. A., Helgason, H. H., Bosma, A. J., Hauptmann, M., Voest, E. E., Schellens, J. H. M., & Veer, L. J. V. (2011) · British Journal of Cancer · doi:10.1038/bjc.2011.164 · Cited by 51
Diverse somatic mutation patterns and pathway alterations in human cancers
Kan, Z., Jaiswal, B. S., & Seshagiri, S. (2010) · Genome biology · doi:10.1186/gb-2010-11-s1-p37 · Cited by 49
Graves, H. L., & Czerniecki, B. J. (2011) · Pathology Research International · doi:10.4061/2011/621090 · Cited by 37
Single Circulating Tumor Cell Detection and Overall Survival in Non Metastatic Breast Cancer.
Bidard, F., Mathiot, C., Mefti, F., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.sabcs-09-3017 · Cited by 20
Bear, H. D. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.0474 · Cited by 6
Cited by
Challenges in circulating tumour cell research
Alix-Panabières, C., & Pantel, K. (2014) · Nature Reviews Cancer · doi:10.1038/nrc3820 · Cited by 1,300
Circulating Tumor Cells: Liquid Biopsy of Cancer
Alix-Panabières, C., & Pantel, K. (2013) · Clinical Chemistry · doi:10.1373/clinchem.2012.194258 · Cited by 1,134
Molecular analysis of circulating tumour cells—biology and biomarkers
Krebs, M. G., Metcalf, R. L., Carter, L., Brady, G., Blackhall, F. H., & Dive, C. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.253 · Cited by 622
Biology, detection, and clinical implications of circulating tumor cells
Joosse, S. A., Gorges, T. M., & Pantel, K. (2015) · EMBO Molecular Medicine · doi:10.15252/emmm.201303698 · Cited by 528
Circulating tumor cell technologies
Ferreira, M. M., Ramani, V. C., & Jeffrey, S. S. (2016) · Molecular Oncology · doi:10.1016/j.molonc.2016.01.007 · Cited by 511
Metadata
- Authors
- L�cke, K.
- Venue
- International Journal of Oncology
- Publisher
- Spandidos Publications
- Published
- 2012-07-16
- Volume
- 41
- Issue
- 4
- Pages
- 1241-50
- ISSN
- 1019-6439 (ISSN-L)
- 1791-2423
- OpenAlex
- W2111304055
- Cited by
- 314
- References
- 49
- FWCI
- 6.98
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.